Recurrent Respiratory Papillomatosis in the Post-Human Papillomavirus Vaccination Era
- PMID: 39432273
- PMCID: PMC11581739
- DOI: 10.1001/jamapediatrics.2024.4422
Recurrent Respiratory Papillomatosis in the Post-Human Papillomavirus Vaccination Era
Plain language summary
This cross-sectional study examines the incidence of juvenile-onset recurrent respiratory papillomatosis and HPV vaccination rates from 2007 to 2022 in the US.
Conflict of interest statement
References
-
- MarketScan Redbook version 2.2. Stanford Center for Population Health Sciences. Accessed June 11, 2024. doi:10.57761/ra62-g951. - DOI
-
- Marsico M, Mehta V, Chastek B, Liaw KL, Derkay C. Estimating the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis in publicly and privately insured claims databases in the United States. Sex Transm Dis. 2014;41(5):300-305. doi:10.1097/OLQ.0000000000000115 - DOI - PubMed
-
- Vaccination coverage among adolescents 13-17 years. Centers for Disease Control and Prevention . Accessed July 4, 2024. https://data.cdc.gov/Teen-Vaccinations/Vaccination-Coverage-among-Adoles...
LinkOut - more resources
Full Text Sources